Acerus Reports Second Quarter 2022 Financial Results
August 09, 2022 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three and six-month...
Acerus Announces Amendments to Loan Facility and Promissory Note Due to Former Serenity Shareholders
August 05, 2022 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it has entered into an amending agreement with...
Acerus to Report Q2-2022 Financial Results and Host Investor Call
August 03, 2022 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2022 financial and operating results on Tuesday, August 9, 2022...
Acerus Announces Voting Results for the 2022 Annual Meeting
June 27, 2022 17:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced the voting results from its annual meeting of shareholders held on...
Acerus Announces Amendments to Loan Facility
June 24, 2022 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it has entered into an amending agreement with...
Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders
June 07, 2022 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, June 07, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCD) today announced that it has entered into an amended and restated...
Acerus Reports First Quarter 2022 Financial Results
May 10, 2022 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three-month period...
Acerus To Report Q1-2022 Financial Results And Host Investor Call
May 05, 2022 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, May 05, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCD) will announce its first quarter 2022 financial and operating results on Tuesday, May 10, 2022...
Acerus Announces Completion of Share Consolidation
April 26, 2022 18:00 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, April 26, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) announced that further to its news release from April 19, 2022, the...
Acerus Announces Share Consolidation
April 19, 2022 17:00 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, April 19, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that the Company intends to undertake a...